Home » Topics » BioWorld Science

BioWorld Science
RSS

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Aug. 31, 2021

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

Aug. 31, 2021

New heart failure animal model also captures arrhythmia susceptibility

Aug. 31, 2021

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

Aug. 31, 2021

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Aug. 31, 2021

U.K. researchers synthesize new antifungals

Aug. 31, 2021

TroBio Therapeutics presents new compounds for cancer

Aug. 31, 2021

Mindset Pharma patents 5-HT2A receptor agonists

Aug. 31, 2021

Janssen Biotech divulges DHODH inhibitors

Aug. 31, 2021

Increased atrial proarrhythmic activity seen in murine model of OSA

Aug. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...